U.S. stocks saw a decline on Monday as investors braced for a critical week, with attention focused on the Federal Reserve’s upcoming policy meeting. The Dow Jones Industrial Average slipped 0.5%, the S&P 500 decreased by 0.3%, while the tech-heavy Nasdaq Composite remained nearly unchanged. This dip follows a week of gains for major indices, raising questions about market sentiment ahead of potential interest rate changes.
Expectations are building that the Fed will cut interest rates during its two-day meeting starting Tuesday, with current market assessments indicating an 88% probability of a rate cut on Wednesday. This marks a notable increase from 67% expectations just a month ago, driven by a gentle reading on September’s PCE consumer inflation that maintained investor confidence. While there is a consensus on a third cut for 2025, skepticism lingers about the Fed’s direction in 2026, partly due to a division among policymakers regarding priorities between the labor market and inflation, which some continue to view as persistently high.
This week’s economic data will be crucial, particularly regarding the labor market, as several reports are set to be released. The October Job Openings and Labor Turnover Survey (JOLTS), which has been delayed, is expected to arrive on Tuesday, offering insights into hiring trends, layoffs, and resignation rates.
In corporate news, Warner Bros. Discovery’s stock surged over 7% in early trading after rival Paramount launched a $108 billion hostile bid for the media company, complicating Netflix’s previous plans to acquire it. On the earnings front, key reports from Oracle and Adobe are anticipated midweek, followed by results from Broadcom and Costco on Thursday.
Notably, there were major stock movements within the tech sector as well. CoreWeave, backed by Nvidia, saw shares tumble nearly 7% following news of a $2 billion private debt offering that raised fears of stock dilution. The company’s strategy involves issuing senior convertible notes, which can be exchanged for shares under certain conditions, prompting concerns over its existing debt of approximately $14 billion.
Meanwhile, Structure Therapeutics experienced a remarkable 72% share price increase after announcing positive results for its oral GLP-1 obesity pill, which demonstrated a weight loss of 11.3% in a mid-stage trial. These results pave the way for further trials slated for 2026, as the market continues to see a fierce competition among pharmaceutical companies developing oral versions of injectable GLP-1 medications.
Investments in the entertainment sector also saw significant movements. Investors shifted their focus to the potential impacts of acquisitions, creating ripples across the market. Stocks like Carvana gained 8% on news of its inclusion in the S&P 500, while Rivian fell by 3% due to a major vehicle recall.
Additionally, IBM announced its agreement to acquire data streaming platform Confluent for $11 billion in a move aimed at enhancing its cloud software capabilities and tapping into the growing AI applications market. Confluent shares jumped nearly 30% post-announcement, reflecting market enthusiasm for this strategic move.
Finally, crude oil prices dipped in early trading as investors anticipated the Fed’s decisions and due to stalled peace talks between Russia and Ukraine. West Texas Intermediate futures fell 1.2%, trading below $60 per barrel, influenced by the geopolitical climate and Fed expectations.
Overall, as U.S. markets navigate through this critical week, investors remain attentive to economic signals and corporate developments that may shape the financial landscape in the near future.
